Selective CYP11B1 inhibtors as a novel treatment option for endogenous cortisol excess

Lavery, Gareth (Co-Investigator)
Arlt, Wiebke (Principal Investigator)

Metabolism and Systems Research

Short title	Selective CYP11B1 inhibtors as a novel treatment option for endogenous cortisol excess
Status	Finished
Effective start/end date	4/01/18 → 3/09/22

Funding

Medical Research Council

1 Article

Urine steroid metabolomics as a diagnostic tool in primary aldosteronism
Prete, A., Lang, K., Pavlov, D., Rhayem, Y., Sitch, A. J., Franke, A. S., Gilligan, L. C., Shackleton, C. H. L., Hahner, S., Quinkler, M., Dekkers, T., Deinum, J., Reincke, M., Beuschlein, F., Biehl, M. & Arlt, W., 1 Mar 2024, In: The Journal of Steroid Biochemistry and Molecular Biology. 237, 106445.
Research output: Contribution to journal › Article › peer-review

Open Access
File
11 Downloads (Pure)